Inventor · disambiguated record
Yasushi Ochiai
Also filed as: OCHIAI YASUSHI
9 granted patents·22 pending applications·43 citations·filing 2002–2023
84Inventor score
Files withDAINIPPON SUMITOMO PHARMA CO6SEKISUI MEDICAL CO LTD6SUMITOMO PHARMA CO LTD6SUMITOMO DAINIPPON PHARMA CO LTD5IKEDA YUKI2
Top patents by PatentIndex Score
31 records- 0191US8377995B2Orally disintegrating tabletDAINIPPON SUMITOMO PHARMA CO·Filed 2008·Granted Feb 19, 2013·12 cites·15 claims
- 0280US7192608B2Method of manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granulesDAINIPPON SUMITOMO PHARMA CO·Filed 2002·Granted Mar 20, 2007·21 cites·2 claims
- 0379US10034880B2Ophthalmic suspension formulationSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Jul 31, 2018·2 cites·24 claims
- 0476US8192761B2Granular preparation containing biguanide compoundOCHIAI YASUSHI·Filed 2006·Granted Jun 5, 2012·4 cites·23 claims
- 0570US2023240994A1Medicament-containing hollow particleSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0667US8980316B2Stable tablet containing droxidopaOCHIAI YASUSHI·Filed 2006·Granted Mar 17, 2015·2 cites·29 claims
- 0762US2019254976A1Medicament-containing hollow particleSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 0859US7429588B2Crystalline isoxazole derivative and medical preparation thereofDAINIPPON SUMITOMO PHARMA CO·Filed 2002·Granted Sep 30, 2008·2 cites·2 claims
- 0957US11369701B2Ri-labeled humanized antibodyNIHON MEDIPHYSICS CO LTD·Filed 2021·Granted Jun 28, 2022·0 cites·18 claims
- 1057US2015297520A1Medicament-containing hollow particleSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 1157US2011053942A1Orally disintegrating tabletsDAINIPPON SUMITOMO PHARMA CO·Filed 2009·Application pending·0 cites
- 1257US2010093875A1Granular preparation prevented from cakingDAINIPPON SUMITOMO PHARMA CO·Filed 2007·Application pending·0 cites
- 1356US2019290579A1Orally disintegrating tablet having inner coreMATONO MITSUHIRO·Filed 2018·Application pending·0 cites
- 1455US2024377396A1Immunoassay method, specimen diluent, and immunochromatography kitSEKISUI MEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 1555US2018228733A9Medicament-containing hollow particleSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 1654US2024189461A1Humanised antibodies labelled with radionuclides that emit beta-raysNIHON MEDIPHYSICS CO LTD·Filed 2022·Application pending·0 cites
- 1752US2024032850A1Evaluation device, method, and program for evaluating ability to identify objectSUMITOMO PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1852US2024241120A1Sars-cov-2 immunoassay method and immunoassay kit, and monoclonal antibody or antibody fragment thereofSEKISUI MEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 1951US2024255505A1Sars-cov-2 immunoassay method and immunoassay kitSEKISUI MEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 2051US2008311212A1Crystalline isoxazole derivative and pharmaceutical preparation thereofDAINIPPON SUMITOMO PHARMA CO·Filed 2008·Application pending·0 cites
- 2150US2024382132A1Brain wave measurement deviceSUMITOMO PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2249US2021338170A1Method, device, and program for assessing relevance of respective preventive interventional actions to health in health domain of interestSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 2349US2024374200A1Biological information recording device and biological information recording programSUMITOMO PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2448US2023172527A1Three-dimensional cognitive ability evaluation systemSUMITOMO PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 2548US2021302426A1Method for immunologically detecting mycoplasma pneumoniaeSEKISUI MEDICAL CO LTD·Filed 2019·Application pending·0 cites
- 2647US2024377192A1Stereognostic Ability Evaluation System, Stereognostic Ability Evaluation Device, Stereognostic Ability Evaluation Program, and Stereognostic Ability Evaluation MethodSUMITOMO PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2746US2011305758A1Orally disintegrating tablet having inner coreMATONO MITSUHIRO·Filed 2010·Application pending·0 cites
- 2836US8920839B2Dry-coated orally-disintegrating tabletIKEDA YUKI·Filed 2010·Granted Dec 30, 2014·0 cites·6 claims
- 2932US2019145970A1Immunochromatographic detection methodSEKISUI MEDICAL CO LTD·Filed 2017·Application pending·0 cites
- 3031US9278063B2Press-coated orally-disintegrating tabletsIKEDA YUKI·Filed 2010·Granted Mar 8, 2016·0 cites·14 claims
- 3130US2018088110A1Immunological detection method and test strip used thereforSEKISUI MEDICAL CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yasushi Ochiai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →